Company Filing History:
3 out of 5,089 
3 out of 170 
2 out of 223 
Years Active: 2019-2022
Title: Gérard Demangeat: Innovator in Virus-Like Particle Technology
Introduction
Gérard Demangeat is a notable inventor based in Ostheim, France. He has made significant contributions to the field of biotechnology, particularly in the development of virus-like particles. With a total of 3 patents, his work has implications in various sectors, including pharmaceuticals and agriculture.
Latest Patents
Demangeat's latest patents include innovative technologies that utilize virus-like particles. One of his key inventions is related to GFLV virus-like particles and their applications in pharmaceutical, agro, and veterinary fields. Another significant patent focuses on novel fusion polypeptides derived from nepoviruses, which can be used to create virus-like particles that encapsulate molecules of interest. These advancements have the potential to revolutionize how certain diseases are treated and managed.
Career Highlights
Throughout his career, Gérard Demangeat has worked with esteemed institutions such as the Centre National De La Recherche Scientifique and the University of Strasbourg. His research has been pivotal in advancing our understanding of virus-like particles and their applications.
Collaborations
Demangeat has collaborated with notable colleagues, including Caroline Hemmer and Christophe Ritzenthaler. These partnerships have enriched his research and contributed to the success of his inventions.
Conclusion
Gérard Demangeat's innovative work in the field of virus-like particles showcases his dedication to advancing biotechnology. His patents and collaborations highlight the importance of research in developing new solutions for various industries.